Research and development
Flow – sum over the period · $M
Q4 2025
30.2a$M
derived
All values (10)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 46.3 | reported |
| Q1 2026 | 41.2 | reported |
| Q4 2025 | 30.2 | derived |
| Q3 2025 | 36.4 | reported |
| Q2 2025 | 34.0 | reported |
| Q1 2025 | 17.6 | reported |
| Q4 2024 | 23.4 | derived |
| Q3 2024 | 18.7 | reported |
| Q2 2024 | 19.4 | reported |
| Q1 2024 | 16.5 | reported |
32 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd
More metrics for Celestica
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Operating income by segment
Sources & calculation
- Value
- $30.0M (derived)
- Period
- Q4 2025, ended Dec 31, 2025 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = 118M − 88M = $30.0M (FY value from 10-K 0001030894-26-000011; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Feb 27, 2026 · 0001030894-26-000011
- Location
- us-gaap:ResearchAndDevelopmentExpense
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $30.0M | Feb 27, 2026 | 10-K 0001030894-26-000011 | derived · confidence 1. · current |